The clinical trials landscape for glioblastoma: is it adequate to develop new treatments?
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The clinical trials landscape for glioblastoma: is it adequate to develop new treatments?
Authors
Keywords
-
Journal
NEURO-ONCOLOGY
Volume -, Issue -, Pages -
Publisher
Oxford University Press (OUP)
Online
2018-03-02
DOI
10.1093/neuonc/noy027
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Designing Clinical Trials That Accept New Arms: An Example in Metastatic Breast Cancer
- (2017) Steffen Ventz et al. JOURNAL OF CLINICAL ONCOLOGY
- Bayesian Baskets: A Novel Design for Biomarker-Based Clinical Trials
- (2017) Lorenzo Trippa et al. JOURNAL OF CLINICAL ONCOLOGY
- Adult Glioblastoma
- (2017) Brian M. Alexander et al. JOURNAL OF CLINICAL ONCOLOGY
- Broadening Eligibility Criteria to Make Clinical Trials More Representative: American Society of Clinical Oncology and Friends of Cancer Research Joint Research Statement
- (2017) Edward S. Kim et al. JOURNAL OF CLINICAL ONCOLOGY
- Future cancer research priorities in the USA: a Lancet Oncology Commission
- (2017) Elizabeth M Jaffee et al. LANCET ONCOLOGY
- Point/counterpoint: randomized versus single-arm phase II clinical trials for patients with newly diagnosed glioblastoma
- (2017) Stuart A. Grossman et al. NEURO-ONCOLOGY
- Master Protocols to Study Multiple Therapies, Multiple Diseases, or Both
- (2017) Janet Woodcock et al. NEW ENGLAND JOURNAL OF MEDICINE
- Current status and perspectives of interventional clinical trials for glioblastoma – analysis of ClinicalTrials.gov
- (2017) Nikola Cihoric et al. Radiation Oncology
- Complete prevalence of malignant primary brain tumors registry data in the United States compared with other common cancers, 2010
- (2016) Adah S. Zhang et al. NEURO-ONCOLOGY
- Withholding temozolomide in glioblastoma patients with unmethylatedMGMTpromoter—still a dilemma?: Table 1.
- (2015) Monika E. Hegi et al. NEURO-ONCOLOGY
- Combining progression-free survival and overall survival as a novel composite endpoint for glioblastoma trials
- (2015) Lorenzo Trippa et al. NEURO-ONCOLOGY
- CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2008-2012
- (2015) Quinn T. Ostrom et al. NEURO-ONCOLOGY
- Compliance with Results Reporting at ClinicalTrials.gov
- (2015) Monique L. Anderson et al. NEW ENGLAND JOURNAL OF MEDICINE
- MGMT testing—the challenges for biomarker-based glioma treatment
- (2014) Wolfgang Wick et al. Nature Reviews Neurology
- Progression-free survival: too much risk, not enough reward?
- (2014) B. M. Alexander et al. NEURO-ONCOLOGY
- Brain Malignancy Steering Committee clinical trials planning workshop: Report from the Targeted Therapies Working Group
- (2014) B. M. Alexander et al. NEURO-ONCOLOGY
- MGMT methylation in glioblastoma: tale of the tail
- (2014) Nameeta Shah et al. NEURO-ONCOLOGY
- A comparison of Bayesian adaptive randomization and multi-stage designs for multi-arm clinical trials
- (2014) James M. S. Wason et al. STATISTICS IN MEDICINE
- Enzastaurin before and concomitant with radiation therapy, followed by enzastaurin maintenance therapy, in patients with newly diagnosed glioblastoma without MGMT promoter hypermethylation
- (2013) W. Wick et al. NEURO-ONCOLOGY
- Biomarker-based adaptive trials for patients with glioblastoma--lessons from I-SPY 2
- (2013) B. M. Alexander et al. NEURO-ONCOLOGY
- Linking ClinicalTrials.gov and PubMed to Track Results of Interventional Human Clinical Trials
- (2013) Vojtech Huser et al. PLoS One
- Bayesian Adaptive Randomized Trial Design for Patients With Recurrent Glioblastoma
- (2012) Lorenzo Trippa et al. JOURNAL OF CLINICAL ONCOLOGY
- Detecting an Overall Survival Benefit that Is Derived From Progression-Free Survival
- (2009) Kristine R. Broglio et al. JNCI-Journal of the National Cancer Institute
- Commentary: Practicing on the Tip of an Information Iceberg? Evidence of Underpublication of Registered Clinical Trials in Oncology
- (2008) S. Ramsey et al. ONCOLOGIST
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started